A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects

Inclusion Criteria: * Those who are fully informed of and understand this study and have signed the Informed Consent Form. * Those who are willing to follow and able to complete all the trial procedures. * Female subjects of childbearing potential must agree to abstinence or take effective contraceptive measures during the trial and at least 70 days (10 weeks) after administration. * Male subjects must agree to abstinence or use condoms as a contraceptive measure during the trial and at least 70 days (10 weeks) after administration. * Sex: male or female. * Age: 18-45 years, including 18 and 45 years. * BMI: 19.0-26.0 kg/m2, including 19.0 and 26.0 kg/m2. * Those who do not smoke, or have smoked less than 5 cigarettes per day within 3 months before screening; those who do not drink alcohol, or have drunk less than 14 units of alcohol per week (1 unit of alcohol = 360 mL of beer or 45 mL of spirits with 40% alcohol content or 150 mL of wine) within 6 months before screening; those who have not smoked or drunk alcohol within 48 hours before admission to the study site. * Subjects whose clinical laboratory test results are within the normal range or whose test results are abnormal but judged by the investigator to be of no clinical insignificance. * Those with a positive 14C urea breath test (UBT) result. Exclusion Criteria: * Those with an allergic constitution, a history of allergic diseases or a history of drug allergy. * Those with a history of alcohol or drug abuse in th…